Varicose Veins Treatment Market Size & Share, by Product (Ablation Devices, Sclerotherapy Injections); Procedure (Injection Sclerotherapy, Endovenous Ablation, Surgical Ligation) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4936
  • Published Date: May 04, 2023
  • Report Format: PDF, PPT

Companies Dominating the Varicose Vein Treatment Landscape

top-features-companies
    • Candela Medical
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Medtronic PLC
    • Boston Scientific
    • El. En SpA Group
    • Teleflex Incorporated
    • Eufoton SRL
    • Biolitec AG (BioMed Technology Holdings Ltd)
    • AngioDynamics Inc.
    • Alma Lasers Ltd
    • Sciton Inc.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Medtronic has initiated an Investigation Device Exemption study for the assessment of the efficacy and safety of the Abre Venous Self-expanding Stent System intended to treat Deep Lymphocytic Diseases in order to establish its effectiveness and safety. It is likely that this study will be conducted at 35 locations across the United States and Europe, involving about 200 subjects.
  • IVASC, an Italian medical device company, completed a EUR 1.8 million Series A investment in April 2022 for the launch of its VELEX product. VELEX, which received CE Mark in May 2021, is a device that can be used to treat CVI and varicose veins with a procedure called Empty Vein Ablation (EVA).

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4936
  • Published Date: May 04, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The major factors driving the growth of the market are increasing varicose vein global burden, and surging preference for minimally invasive treatment procedures.

The market size of varicose vein treatment is anticipated to attain a CAGR of 9.9% over the forecast period, i.e., 2023-2035.

The major players in the market are Candela Medical, Medtronic PLC, Boston Scientific, El. En SpA Group and others.

The ablation devices segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

The market in the North America region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying